Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus
Top Cited Papers
- 1 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 236 (2), 177-183
- https://doi.org/10.1097/00000658-200208000-00005
Abstract
Objective To determine the prevalence of occult cervical nodal metastases in patients with squamous cell cancer and adenocarcinoma of the esophagus, and to determine the impact of esophagectomy with three-field lymph node dissection on survival and recurrence rates. Summary Background Data Although esophagectomy with three-field lymph node dissection is commonly practiced in Japan, its role in the surgical management of esophageal cancer in the United States, especially in patients with esophageal adenocarcinoma, is essentially unknown. Methods This is a prospective observational study of esophagectomy with three-field lymphadenectomy. Eighty patients underwent resection between August 1994 and April 2001. Clinicopathological information and follow-up data were collected on all patients until death or June 2001. Results Hospital mortality and morbidity rates were 5% and 46%, respectively. Metastases to the recurrent laryngeal and/or deep cervical nodes occurred in 36% of patients irrespective of cell type (adenocarcinoma 37%, squamous 34%) or location within the esophagus (lower third 32%, middle third 60%). Overall 5-year and disease-free survival rates were 51% and 46%, respectively. Sixty-nine percent presented with nodal metastases. The 5-year survival rate for node-negative patients was 88%; that for those with nodal metastases was 33%. The 5-year survival rate in patients with positive cervical nodes was 25% (squamous 40%, adenocarcinoma 15%). Conclusions Esophagectomy with three-field lymph node dissection can be performed with a low mortality and reasonable morbidity. Unsuspected metastases to the recurrent laryngeal and/or cervical nodes are present in 36% of patients regardless of cell type or location within the esophagus. Thirty percent of patients were upstaged, mainly from stage III to stage IV. An overall 5-year survival rate of 51% suggests a true survival benefit beyond that achieved solely on the basis of stage migration.Keywords
This publication has 16 references indexed in Scilit:
- En bloc esophagectomy improves survival for stage III esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Occult cervical nodal metastasis in esophageal cancer: Preliminary results of three-field lymphadenectomyThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Editorial on “occult cervical nodal metastases in esophageal cancer: Preliminary results of three-field lymphadenectomy”The Journal of Thoracic and Cardiovascular Surgery, 1997
- Mortality and Morbidity Rates, Postoperative Course, Quality of Life, and Prognosis After Extended Radical Lymphadenectomy for Esophageal GancerAnnals of Surgery, 1995
- Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinomaThe Annals of Thoracic Surgery, 1994
- Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagusBritish Journal of Surgery, 1994
- Long-Term Results of Subtotal Esophagectomy with Three-Field Lymphadenectomy for Carcinoma of the Thoracic EsophagusAnnals of Surgery, 1994
- Lymph node metastasis in thoracic esophageal carcinomaJournal of Surgical Oncology, 1991
- Results of a Nationwide Study on the Three-Field Lymph Node Dissection of Esophageal CancerOncology, 1991
- Multivariate approach for assessing the prognosis of clinical oesophageal carcinomaBritish Journal of Surgery, 1988